No label defined (Q31120)

From lgbtDB
Jump to navigation Jump to search
No description defined
  • Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.
Language Label Description Also known as
English
No label defined
No description defined
  • Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.

Statements

Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review. (English)
1 reference
In transgender individuals assigned female at birth, testosterone therapy is employed for body masculinization. (English)
1 reference
Guidelines recommend close monitoring for potential side effects of hormonal therapy, especially during the first year. (English)
1 reference
Erythrocytosis is a common finding during testosterone therapy and has been associated with a potential risk of thrombotic and cardiovascular events. (English)
1 reference
Currently, the hematologic effects of testosterone therapy are understudied, with existing data primarily derived from the cisgender male population. (English)
1 reference
The aim of this study was to comprehensively examine the hematological changes induced by testosterone therapy in the transgender population. (English)
1 reference
A systematic search was conducted using the electronic database PubMed. (English)
1 reference
Thirty-six manuscripts were retrieved. (English)
1 reference
After screening for original studies, 19 articles were included. (English)
1 reference
Selected articles were published between 2005 and 2023. (English)
1 reference
In our systematic review, the prevalence of erythrocytosis varied from 0% to 29.3%, with severe erythrocytosis ranging from 0.5% to 2.3%. (English)
1 reference
Testosterone therapy was associated with an increase in hemoglobin and hematocrit, particularly within the first year of therapy. (English)
1 reference
Factors such as serum testosterone levels, along with the duration, doses, and formulation of testosterone therapy, were found to be associated with the development of erythrocytosis. (English)
1 reference
Further research is crucial to provide specific recommendations for clinical practice. (English)
1 reference
June 2024
1 reference
June 2024
1 reference
Gender Incongruence Interdisciplinary Group (English)
1 reference
49
1 reference
2
1 reference
205-216
1 reference
205
1 reference
216
1 reference
unknown value
1 reference
Andrea (English)
Garolla (English)
1 reference
1 reference
1 reference
Camillo (English)
Barbisan (English)
1 reference
Valentina (English)
Camozzi (English)
1 reference
Elena (English)
Campello (English)
1 reference
Annamaria (English)
Cattelan (English)
1 reference
1 reference
Fabrizio (English)
Dal Moro (English)
1 reference
Giorgio (English)
DE Conti (English)
1 reference
Angela (English)
Favaro (English)
1 reference
Alberto (English)
Ferlin (English)
1 reference
Francesco (English)
Francini (English)
1 reference
Michela (English)
Gatta (English)
1 reference
1 reference
Sandro (English)
Giannini (English)
1 reference
Laura (English)
Guazzarotti (English)
1 reference
Massimo (English)
Iafrate (English)
1 reference
Paolo (English)
Meneguzzo (English)
1 reference
Marina (English)
Miscioscia (English)
1 reference
Giancarlo (English)
Ottaviano (English)
1 reference
Carlo (English)
Saccardi (English)
1 reference
Lolita (English)
Sasset (English)
1 reference
Alberto (English)
Scala (English)
1 reference
Rossana (English)
Schiavo (English)
1 reference
Giuseppe (English)
Sergi (English)
1 reference
Paolo (English)
Simioni (English)
1 reference
Benedetta (English)
Tascini (English)
1 reference
Francesca (English)
Venturini (English)
1 reference
Fabrizio (English)
Vianello (English)
1 reference